Francis Collins, MD/PhD – NIH Director

Director, National Institutes of Health

As NIH Director, Dr. Collins oversees the work of the largest supporter of biomedical research in the world, spanning the spectrum from basic to clinical research. Dr. Collins is a physician-geneticist noted for his landmark discoveries of disease genes and his leadership of the international Human Genome Project, which culminated in April 2003 with the completion of a finished sequence of the human DNA instruction book. He served as director of the National Human Genome Research Institute at the NIH from 1993-2008.

France A. Córdova, PhD – NSF Director

Director of the National Science Foundation (NSF)

France A. Córdova, was sworn in as director of NSF on March 31, 2014. Córdova leads the only government science agency charged with advancing all fields of scientific discovery, technological innovation, and science, technology, engineering and mathematics (STEM) education. NSF's programs and initiatives keep the United States at the forefront of science and engineering, empower future generations of scientists and engineers, and foster U.S. prosperity and global leadership.

Walter Koroshetz, MD – NINDS

Director of the National Institute of Neurological Disorders and Stroke (NINDS)
Co-chair, BRAIN Initiative Multi-Council Working Group (MCWG)

Walter J. Koroshetz, M.D. was selected Director of NINDS on June 11, 2015. Dr. Koroshetz joined NINDS in 2007 as Deputy Director, and he served as Acting Director from October 2014 through June 2015. Before joining NINDS, Dr. Koroshetz served as Vice Chair of the neurology service and Director of stroke and neurointensive care services at Massachusetts General Hospital (MGH).

Fay Lomax Cook, PhD – NSF

Assistant Director for the NSF Directorate for Social, Behavioral & Economic Sciences (SBE)
Co-lead with Jim Olds of NSF Neuroscience

In her role as head of the Directorate for Social, Behavioral and Economic Sciences, Cook will be a key member of the National Science Foundation’s senior management and policy team. She will direct an SBE staff of 119 and manage a budget of approximately $250 million. Dr. Cook was Director of the Institute for Policy Research at Northwestern from 1996 to 2012 and past President of the Gerontological Society.

Jo Handelsman, PhD – OSTP Associate Director for Science

Associate Director for Science at the White House Office of Science and Technology Policy
Co-Chair of the Interagency Working Group on Neuroscience

Dr. Handelsman helps to advise President Obama on the implications of science for the Nation, ways in which science can inform U.S. policy, and on Federal efforts in support of scientific research. Prior to joining OSTP, Dr. Handelsman was an HHMI Professor in the Department of Molecular, Cellular and Developmental Biology at Yale University.

Amber Story, PhD – NSF

Acting Division Director of the Division of Behavioral & Cognitive Sciences, National Science Foundation
Co-Chair Interagency Working Group on Neuroscience
Former Ex Officio Member of Multi-Council Working Group

The Division of Behavioral & Cognitive Sciences supports research in psychology, anthropology, linguistics, geography, and related fields. Dr. Story received her Ph.D. in social psychology from Cornell University and held several academic positions before joining NSF.

Rockell N. Hankin, LLB – Kavli

Rockell N. Hankin is Chairman of the Board of Semtech Corporation, an analog semiconductor company (Nasdaq) and Chairman of the Board of The Kavli Foundation.

Mr. Hankin has been Chairman or a Board member of seven other listed companies and eleven private companies, as well as other charitable organizations. He has taught courses in business and law at UNC (Charlotte), UCLA and USC Law School.

Robert W. Conn, PhD – Kavli

Robert W. Conn is President and Chief Executive Officer of The Kavli Foundation and Zable Professor and Dean, Emeritus, of the Jacobs School of Engineering at UC San Diego.

Dr. Conn is widely recognized for his academic achievements and leadership in education and research and for his experience in the private sector.

Miyoung Chun, PhD – Kavli

Miyoung Chun is Executive Vice President of Science Programs at The Kavli Foundation.

Dr. Chun’s career spans a wide range of experience in academia and industry. Her academic career began as an Assistant Professor of Biochemistry and a member of Whitaker Cardiovascular Institute at Boston University School of Medicine in 1995. There she taught in the areas of cell biology and molecular medicine, and conducted research in signal transduction of G-protein coupled receptors.

William Vanderlinde, PhD – IARPA

Director, IARPA Office of Safe and Secure Operations (SSO)

Dr.Vanderlinde was an IARPA program manager from 2009 to 2012, leading the CAT and ATHENA programs. He re-joined IARPA in March 2015 as the SSO office director. Dr. Vanderlinde’s work has focused on microelectronics and advanced microscopy, with applications to supply-chain assurance and high-performance computing.

Catherine Cotell, PhD – IARPA

Director, IARPA Incisive Analysis (IA) Office

Dr. Cotell’s career has been dedicated to delivering innovative technology-based solutions to both the Intelligence Community (IC) and the Department of Defense. Dr. Cotell holds seminal patents in the field of laser deposition of biocompatible coatings for medical implants.

Rita Bush, PhD – IARPA

Acting Director, IARPA Office for Anticipating Surprise
Program Manager. ICArUS program

Dr. Bush previously served as Division Chief of the Information Exploitation (InfoX) Research Division in the Disruptive Technology Office (DTO), where she oversaw an extensive research portfolio in a variety of topics of interest to the Intelligence Community, including natural language understanding, video exploitation, collaborative work environments, social network analysis, modeling and simulation and information visualization.

Chris Reed, PhD – IARPA

Acting Director, Office of Smart Collection
Program Manager, Athena, GHO, HFGeo, SLiCE

Dr. Reed has been an IARPA program manager since 2010, managing programs and projects on diverse topics that include geolocation, electrically small antennas, and reliability of information from sensor networks. He has been involved in all development phases for systems for signals intelligence, communications, navigation, radar, and electronic warfare. He has patents in parallel computing, radar signal processing, and GPS.

Alexis Jeannotte, PhD – IARPA

Program Manager, IARPA SHARP and TRUST programs

Dr. Jeannotte held an AAAS Science and Technology Policy Fellowship in the National Securities and Global Securities at the US Department of Homeland Security. Dr Jeannotte also was a contractor supporting the government in the development and management of programs that fund research and development to meet national security needs.

Tom Kalil – OSTP Deputy Director for Policy

Deputy Director for Policy for the White House Office of Science and Technology Policy
Senior Advisor for Science, Technology and Innovation for the National Economic Council

Tom Kalil has been the OSTP Director spearheading the convening of the BRAIN Initiative. Tom supervises a team of 14 policy entrepreneurs working science, technology and innovation policy issues such as the President's Strategy for American Innovation, Grand Challenges, STEM education, lab-to-market, R&D funding, insights from the social and behavioral science, and national S&T initiatives.

Monica Ramirez Basco, PhD – OSTP

Assistant Director for Neuroscience, Mental Health, and Broadening Participation at the White House Office of Science and Technology Policy.

Dr. Basco is an internationally recognized expert in cognitive-behavioral therapy, a clinical psychologist, and a founding fellow of the Academy of Cognitive Therapy. She is on the Psychology faculty at the University of Texas at Arlington, with a secondary appointment in Psychiatry at the University of Texas Southwestern Medical Center at Dallas. Her books include bestsellers Never Good Enough and The Bipolar Workbook.

William Newsome, PhD – Stanford

Director of the Stanford Neurosciences Institute and Professor of Neurobiology
HHMI scientist
Co-Chair, Advisory Committee to the NIH Director

Dr. Newsome's research focuses on the neural mechanisms underlying visually based decision making and related issues in cognitive neuroscience. He seeks to understand how higher mammals acquire sensory information about the world, how that information is processed within the brain, and how behavioral responses to that information are organized.

Cori Bargmann, PhD – Rockefeller

Torsten N. Wiesel Professor at Rockefeller University and head of the Lulu and Anthony Wang Laboratory of Neural Circuits and Behavior
Co-chair of the Advisory Committee to the NIH Director (ACD) and At large member of the Multi-Council Working Group (WCWG) for the BRAIN Initiative

Cori Bargmann was awarded the Kavli Prizein 2012 and the Breakthrough Prize in Life Sciences in 2013. Cori is known for her work on the behavior in the C. elegans, particularly olfaction in the worm.

Lyric Jorgenson, PhD – NIH

Acting Director of the Office of Biotechnology Activities, Office of Science Policy at National Institutes of Health
Ex. Secretary for the Advisory Committee to the NIH Director

Dr. Jorgenson provides senior leadership, direction, and oversight of new, high impact NIH scientific initiatives across the NIH Institutes and Centers and conducts analyses on a wide variety of policy issues of high-priority to NIH and the United States Government. Most recently she has assisted in the creation of the National Center for Advancing Translational Sciences and is the lead staff on the BRAIN Initiative at NIH.

Kathy Hudson, PhD – NIH

Deputy Director for Science, Outreach, and Policy at the National Institutes of Health (NIH)
Ex Officio Member for the Advisory Committee to the NIH Director

Dr. Hudson leads the science policy, legislation, communications, and outreach efforts of the NIH and serves as a senior advisor to the NIH director. She is responsible for creating major new strategic and scientific initiatives for NIH and is currently leading the planning and creation of the President’s Precision Medicine Initiative.

Henry T. Greely, JD – Stanford

Professor of Law, Stanford University
Director, Center for Law and the Biosciences
Director, Stanford Program in Neuroscience and Society
At large member, BRAIN Initiative Multi-Council Working Group

Henry Greely specializes in the ethical, legal, and social implications of new biomedical technologies, particularly those related to neuroscience, genetics, or stem cell research.

Storey Landis, PhD – NINDS

Former Director of the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health.
At Large Member of Multi-Council Working Group

Neurobiologist Story Landis has spent 19 years at the NINDS, becoming its director in 2003 after 8 years as scientific director. She helped develop NIH programs for young investigators, coordinated neuroscience research across NIH, served as point person for human embryonic stem cell research, and steered an effort to improve the reproducibility of preclinical studies.

Carlos Peña, PhD – FDA

Director, Division of Neurological and Physical Medicine Devices; Office of Device Evaluation; Center for Devices and Radiological Health; MetroHealth Medical Center - Food and Drug Administration
Ex Officio Member of Multi-Council Working Group

Dr. Peña is involved in all aspects of the safety and effectiveness review of neurostimulation, neurodiagnostic, neurosurgical, neurotherapeutic, and physical medicine devices. He also serves as a Principal Investigator on a FDA sponsored clinical study focused on the treatment of pediatric neurologic disorders.

Justin Sanchez, PhD – DARPA

DARPA program manager exploring neurotechnology, brain science and systems neurobiology, formerly Director of the Neuroprosthetics Research Group at Miami
Ex Officio Member of Multi-Council Working Group

Dr. Sanchez has developed new methods for signal analysis and processing techniques for studying the unknown aspects of neural coding and functional neurophysiology. His experience covers in vivo electrophysiology for brain-machine interface design in animals and humans.

R. Jacob Vogelstein

Program Manager, Office of Safe and Secure Operations, Intelligence Advanced Research Projects Activity (IARPA)
Multi-Council Working Group (staff), BRAIN Initiative

As an IARPA Program Manager, Dr. Vogelstein's areas of interest include neural computing, neuromorphic hardware, neuromimetic algorithms, brain-computer interfaces, neural prosthetics, and other topics in applied neuroscience.

Alan Willard, PhD – NINDS

Acting Deputy Director, NINDS, Office Of The Director
Designated Federal Official for the Multi-Council Working Group

Dr. Willard served as the Deputy Director of the NINDS Extramural program, Chief of the Scientific Review Branch and the Referral Officer for NINDS. He was a tenured faculty member at the University of North Carolina at Chapel Hill in the Department of Cell & Molecular Physiology and the Curriculum in Neurobiology, where his research interests were in the areas of developmental neurobiology and synaptic physiology.

Greg Farber, PhD – NIMH

Director, Office of Technology Development and Coordination for National Institute of Mental Health (NIMH)
Multi-Council Working Group (Staff)

While at Penn State, Dr. Farber's research included work on structural movies of enzyme action, molecular evolution, and mechanistic enzymology. As Director of TDC, he is responsible for coordinating all technology development and bioinformatics activities at NIMH, overseeing the National Database for Autism Research, managing the Human Connectome Project on behalf of the NIH Neuroscience Blueprint, and overseeing the NIMH small-business program.

Kip Ludwig

Program Director, Neural Engineering at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)
Staff,
Multi-Council Working Group 

Dr. Ludwig is the Scientific Lead for the Translational Devices Program at NINDS, is a Co-Lead of the Project Team responsible for developing and executing three of the six NIH Funding Opportunities Announcements for the B.R.A.I.N. Initiative, and led a trans-NIH planning team in developing the ~$250M Stimulating Peripheral Activity to Relieve Conditions (SPARC) Program to stimulate advances in neuromodulation therapies for organ systems.

Edmund Talley, PhD – NINDS

Program Director, Extramural Research Program for National Institute for Neurological Disorders and Stroke (NINDS)
Multi-Council Working Group (Staff)

Dr. Talley was a Research Assistant Professor at UVA and initiated investigations into the CNS functions of two-pore-domain potassium channels, with an emphasis on their modulation by neurotransmitters and clinically important drugs. His work on these channels included extensive mapping of their CNS expression patterns, identification of molecular bases for their modulation using mutational and biochemical analyses, and investigations into their functions in vivo by generating knockout mouse lines.

Christine Grady, RN/PhD – NIH

Chief of the Department of Bioethics at the National Institutes of Health Clinical Center.
Co-chair of Neuroethics Committee, MCWG - BRAIN Inititative

Dr. Grady's research focuses on the ethics of clinical research, especially subject recruitment, incentives, vulnerability, informed consent, and international research ethics. She is currently a member of the Presidential Commission for the Study of Bioethical Issues; and also a senior research fellow at the Kennedy Institute of Ethics and an elected fellow at the American Academy of Nursing and at the Hastings Center.

Amy Adams, PhD – NINDS

Director, Office of Scientific Liaison, NINDS

Dr Adams leads OSL efforts to provide a seamless flow of information on research advances and initiatives to the various stakeholders including scientific and academic communities, as well as policy-makers, patients, and the public.

Geoffrey Ling, MD, PhD – DARPA

Director, Biological Technologies Office, DARPA
Ex Officio member of the Advisory Committee to the NIH Director

Drl Ling's Revolutionizing Prosthetics program developed advanced arm prostheses controlled either non-invasively or directly by a user’s brain. His Preventing Violent Explosive Neuro Trauma program developed new understanding and treatment of blast-induced traumatic brain injury (TBI). He has spent his career providing critical care to patients suffering from neurological trauma (TBI).

Skip to toolbar